SCHEMBL7983440

SCHEMBL7983440

c1ccc(Oc2ccccc2Nc2nc3ccccc3n3cncc23)cc1

nearest known ligand 0.74

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
LCK P06239 19/20 0.74
KDM4E B2RXH2 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7969915 0.85 LCK (1.00) LCKKDM4E
SCHEMBL7981168 0.83 LCK (0.78) LCKKDM4E
SCHEMBL7987162 0.82 LCK (0.73) LCKKDM4E
SCHEMBL7983035 0.82 LCK (0.73) LCK
SCHEMBL7980203 0.79 LCK (0.83) LCKKDM4E
SCHEMBL7981902 0.79 LCK (1.00) LCK
SCHEMBL7979866 0.79 LCK (1.00) LCK
SCHEMBL7984726 0.79 LCK (0.72) LCK
SCHEMBL7970028 0.78 LCK (0.77) LCKKDM4E
SCHEMBL4931040 0.78 LCK (1.00) LCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6235740-B1 AUTOIMMUNE DISEASES; ANTIPROLIFERATION AGENTS BRISTOL-MYERS SQUIBB CO. 2001-05-22 US claimed
WO-1999009845-A1 IMIDAZOQUINOXALINE PROTEIN TYROSINE KINASE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 1999-03-04 WO claimed
US-6235740-B1 AUTOIMMUNE DISEASES; ANTIPROLIFERATION AGENTS BRISTOL-MYERS SQUIBB CO. 2001-05-22 US disclosed